Work

Supplementary Tables 1 - 5 from Targeting the NF-κB and mTOR Pathways with a Quinoxaline Urea Analog That Inhibits IKKβ for Pancreas Cancer Therapy

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 53K, Table S1: Pancreatic cancer cell growth inhibition by 13-197; Table S2: % Neutrophils upon prolonged treatment with 13-197; Table S3: Metastases in mice treated with 13-197; Table S4: Immunohistochemical analysis of tumor samples; Table S5: Inflammation and Necrosis in tumor tissues

DOI: 10.1158/1078-0432.22450824.v1

Authors: Prakash Radhakrishnan, Vashti C. Bryant, Elizabeth C. Blowers, Rajkumar N. Rajule, Nagsen Gautam, Muhammad M. Anwar, Ashley M. Mohr, Paul M. Grandgenett, Stephanie K. Bunt, Jamie L. Arnst, Subodh M. Lele, Yazen Alnouti, Michael A. Hollingsworth, Amarnath Natarajan

Language: English

Topic: NF-κB Signaling Pathways

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361908387

Cites:

Cited by:

Related to: 10